SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mr. Forthright who wrote (1973)	6/28/1998 11:05:00 AM
From: Turboe	Read Replies (1) of 5402

To: drdan (1931 ) From: Mr. Forthright Saturday, Jun 27 1998 9:27AM ET Reply # of 1974 I think you are way to optimistic and are making statements that need to be clarified: <<As long as the drug gets thru Phase One testing without any surprises about toxicity, pharm firms will be falling over themselves to buy into this company.>> How can you say that? I know biotech companies in Phase 2b and/or 3 that have yet to sign up deals with big pharma. Also the risks of failure after Phase 1 are still extremely high. It is the nature of the business. SGNC may have the right scientific approach and may eventually get approved but that is years away and trust me the odds of you still being on the Internet promoting SGNC everyday for the next 5 years are very low: you will get bored with that long before it gets anywhere near approval. The problem I have with your post is that to the unsophisticated investor you may look like you know what you are talking about. To me, who has financed several biotech firms over the years, you clearly appear to be a neophyte. I wouldn't want small investors to get the wrong impression with respect to your statement.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next